TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway

Ying Xing(Nanjing University of Science and Technology), Li Cai(Wenzhou Medical University), Wei Liu(Jiangsu Province Hospital), Chunhong Li(Guilin Medical University), Jing Hu(Southeast University), Qingwei Meng(Shandong Agricultural University), Jian Huang(Harbin Medical University), Tianbo Liu(Harbin Medical University), Hailing Lu(Harbin Medical University), Yuechao Liu(Harbin Medical University), Mengru Cao(Nippon Medical School), Ting Wang(Jilin University)
Cell Communication and Signaling
July 31, 2018
10.1186/s12964-018-0254-x
Cited by 103

Related Papers

Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma
|Cell Metabolism|2018|420
Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment
|JAMA|2020|229
Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway
|Acta Pharmacologica Sinica|2016|182
Emerging agents that target signaling pathways in cancer stem cells
|Journal of Hematology & Oncology|2020|176
MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells
|International Journal of Oncology|2012|169